Spero Therapeutics (SPRO) P/E (2018 - 2026)
Spero Therapeutics (SPRO) P/E from Jan 2, 2018 to Jul 21, 2026. The TTM Spero Therapeutics (SPRO) P/E is 5.05. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Spero Therapeutics (SPRO)
| Year | P/E | Change |
|---|---|---|
| 2026 | 5.05 | -67.62% |
| 2025 | 15.61 | -2015.73% |
| 2024 | -0.81 | -98.39% |
| 2023 | -50.67 | +8678.92% |
| 2022 | -0.58 | -89.61% |
| 2021 | -5.55 | -4.28% |
| 2020 | -5.80 | +95.96% |
| 2019 | -2.96 | +26.45% |
| 2018 | -2.34 | N/A |
Comparison Spero Therapeutics (SPRO) P/E with competitors
Spero Therapeutics (SPRO) P/E is 5.05.